204 related articles for article (PubMed ID: 19818966)
1. Gli1 is a potential target for alleviating multidrug resistance of gliomas.
Cui D; Xu Q; Wang K; Che X
J Neurol Sci; 2010 Jan; 288(1-2):156-66. PubMed ID: 19818966
[TBL] [Abstract][Full Text] [Related]
2. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
3. Aberrant activation of Hedgehog/Gli1 pathway on angiogenesis in gliomas.
Cui D; Chen X; Yin J; Wang W; Lou M; Gu S
Neurol India; 2012; 60(6):589-96. PubMed ID: 23287320
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma.
Yoon JW; Lamm M; Chandler C; Iannaccone P; Walterhouse D
BMC Cancer; 2020 Jun; 20(1):511. PubMed ID: 32493277
[TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells.
Ehtesham M; Sarangi A; Valadez JG; Chanthaphaychith S; Becher MW; Abel TW; Thompson RC; Cooper MK
Oncogene; 2007 Aug; 26(39):5752-61. PubMed ID: 17353902
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy for gliomas based on the expression levels of drug resistant genes].
Matsumoto Y; Morisaki K; Miyake K; Kawanishi M; Kawai N; Ogawa T; Irie K; Kunishio K; Nagao S
No Shinkei Geka; 2001 Jul; 29(7):625-30. PubMed ID: 11517503
[TBL] [Abstract][Full Text] [Related]
8. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
Tanaka S; Kamitani H; Amin MR; Watanabe T; Oka H; Fujii K; Nagashima T; Hori T
J Neurooncol; 2000; 46(2):157-71. PubMed ID: 10894369
[TBL] [Abstract][Full Text] [Related]
9. Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines.
Wang K; Pan L; Che X; Cui D; Li C
J Neurooncol; 2010 Jul; 98(3):319-27. PubMed ID: 20024601
[TBL] [Abstract][Full Text] [Related]
10. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.
Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C
Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712
[TBL] [Abstract][Full Text] [Related]
11. Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma.
Nagane M; Shibui S; Oyama H; Asai A; Kuchino Y; Nomura K
Surg Neurol; 1995 Nov; 44(5):462-8; discussion 468-70. PubMed ID: 8629231
[TBL] [Abstract][Full Text] [Related]
12. Sonic Hedgehog/GLI₁ signaling pathway inhibition restricts cell migration and invasion in human gliomas.
Wang K; Pan L; Che X; Cui D; Li C
Neurol Res; 2010 Nov; 32(9):975-80. PubMed ID: 20444323
[TBL] [Abstract][Full Text] [Related]
13. Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.
Du WZ; Feng Y; Wang XF; Piao XY; Cui YQ; Chen LC; Lei XH; Sun X; Liu X; Wang HB; Li XF; Yang DB; Sun Y; Zhao ZF; Jiang T; Li YL; Jiang CL
CNS Neurosci Ther; 2013 Dec; 19(12):926-36. PubMed ID: 24165291
[TBL] [Abstract][Full Text] [Related]
14. The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.
Lampichler K; Ferrer P; Vila G; Lutz MI; Wolf F; Knosp E; Wagner L; Luger A; Baumgartner-Parzer S
Endocr Relat Cancer; 2015 Oct; 22(5):793-803. PubMed ID: 26219678
[TBL] [Abstract][Full Text] [Related]
15. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
Zhou C; Cheng H; Qin W; Zhang Y; Xiong H; Yang J; Huang H; Wang Y; Chen XZ; Tang J
Oncotarget; 2017 Apr; 8(17):27915-27928. PubMed ID: 28427190
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system.
Valera ET; Lucio-Eterovic AK; Neder L; Scrideli CA; Machado HR; Carlotti-Junior CG; Queiroz RG; Motta FJ; Tone LG
J Neurooncol; 2007 Oct; 85(1):1-10. PubMed ID: 17429576
[TBL] [Abstract][Full Text] [Related]
17. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
Wang H; Zhang SY; Wang S; Lu J; Wu W; Weng L; Chen D; Zhang Y; Lu Z; Yang J; Chen Y; Zhang X; Chen X; Xi C; Lu D; Zhao S
Neuro Oncol; 2009 Dec; 11(6):790-802. PubMed ID: 19289490
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway.
Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C
Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521
[TBL] [Abstract][Full Text] [Related]
19. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Peng B; Liu W; He X
Int J Oncol; 2015 Oct; 47(4):1603-11. PubMed ID: 26323558
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
